Abbott Laboratories

Abbott Laboratories is a diversified global healthcare company recognized for its leadership in medical devices, diagnostics, nutrition, and branded generic pharmaceuticals. Founded in 1888 and headquartered in Abbott Park, Illinois, USA, Abbott serves healthcare providers and patients in more than 160 countries through an extensive portfolio of innovative healthcare technologies.

Within the medical device sector, Abbott is internationally recognized for developing cardiovascular devices, diabetes care technologies, structural heart solutions, electrophysiology systems, neuromodulation devices, and remote patient monitoring technologies. The company’s FreeStyle Libre continuous glucose monitoring (CGM) system has transformed diabetes management worldwide, while its cardiovascular portfolio includes advanced stents, heart valves, vascular closure devices, and cardiac rhythm management technologies.

Abbott invests significantly in research and development, combining digital health, artificial intelligence, connected medical devices, and data analytics to improve patient outcomes and healthcare efficiency. The company operates manufacturing facilities and research centers worldwide while maintaining compliance with stringent international quality standards and regulatory requirements.

With more than a century of healthcare innovation, Abbott continues to develop technologies that help people live healthier lives through early diagnosis, better disease management, and minimally invasive treatment solutions. Its commitment to innovation, quality, and global accessibility has established Abbott as one of the world’s leading medical technology companies.